In Healthcare sector, shares of T2 Biosystems, Inc. were valued at $0.89 and moved -9.14% as of a recent closing trade. A total volume of 2039399 shares were traded versus to average volume of 667.22K shares. T2 Biosystems, Inc. shares have been seen trading -83.46% off its 52 week- peak value and changed 71.17% from its 52 week-bottom price value. The percentage off the 52-week high or low refers to when a stock current price is relative to where it has traded over the last 52 weeks. This gives investors an idea of how much the security has moved in the last year and whether it is trading near the top, middle or bottom of the range.

In terms of T2 Biosystems, Inc. stock price comparison to its moving averages, shares of company are -27.10% away from the 50-day moving average and -22.73% away from 20-day average. If we take a long term observation, shares have been trading at a distance of -50.87% from the 200-day moving average. Moving averages are used as a strong indicator for technical stock analysis and it helps investors in figuring out where the stock has been and also facilitate in determining where it may be possibly heading.

Now have a look at past performance (weekly performance to year to date performance) how T2 Biosystems, Inc. has been moved; whether it performed well or not. T2 Biosystems, Inc. reported a change of -23.92% over the last week and performed -23.92% over the last month while its year to date (YTD) performance revealed an activity trend of -23.92% .The stock’s quarterly performance specifies a shift of -64.25%, and its last twelve month performance is stands at -74.57% while moved 54.00% for the past six months.

P/E ratio of the company is not avilable. The P/E Ratio measures its current share price relative to its per-share earnings. This indicates the dollar amount an investor can expect to invest in a company in order to receive one dollar of that company’s earnings. For investors, Forward P/E ratio allows a quick snapshot of the company’s finances without getting bogged down in the details of an accounting report. The forward price-to-earnings ratio is a powerful, but limited tool. Forward P/E ratio is at not avilable.

Investors of this company earned a return of -1.207 on the assets it owns in past twelve month. The company generated a return on equity (ROE) of 7.579. A high ROE indicates successfully earning more assets and value for its shareholders off its reinvested earnings. A low ROE warns that the company is not generating a good return on its reinvested earnings.

Analyst mean recommendation rating on a stock by the analyst community is at 2.1. Analyst rating score as published on FINVIZ are rated on a 1 to 5 scale. 1 is equivalent to a buy rating, 3 a hold rating, and 5 a sell rating.

In USA Industry, T2 Biosystems, Inc. have 47.46 outstanding shares currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s officers and insiders. The company have shares float of 39.53. Float is the number of shares available for trading of a particular stock. Floating stock is calculated by subtracting closely-held shares and restricted stock from a firm’s total outstanding shares. Closely-held shares are those owned by insiders, major shareholders and employees, while restricted stock refers to insider shares that cannot be traded because of a temporary restriction such as the lock-up period after an initial public offering. A stock with a small float will generally be more volatile than a stock with a large float, apart from having limited liquidity and wider bid-ask spread. Because of these issues, institutional investors seldom invest in low-float stocks.

TTOO RSI (Relative Strength Index) is 25.55. RSI is a technical indicator of price momentum, comparing the size of recent gains to the size of recent losses and establishes oversold and overbought positions. Technical analysts have little regard for the value of a company. They use historic price data to observe stock price patterns to predict the direction of that price going forward. Analysts use common formulas and ratios to accomplish this.

The stock price weekly volatility remained at 9.19% while volatility is standing at 8.10% for the month. Volatility refers to the amount of uncertainty or risk about the size of changes in a security’s value. A higher volatility means that a security’s value can potentially be spread out over a larger range of values. This means that the price of the security can change dramatically over a short time period in either direction. A lower volatility means that a security’s value does not fluctuate dramatically, but changes in value at a steady pace over a period of time. Commonly, the higher the volatility, the riskier the security.